EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness

Shengmiao Chen, Yiran Wu, Yang Gao, Chenxu Wu, Yuetong Wang, Chun Hou, Miao Ren, Shuyuan Zhang, Qi Zhu, Jiali Zhang, Yufeng Yao, Mei Huang und 8 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Shengmiao Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Hauptthemen laut MEDLINE: Dinoprostone, Ovarian Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Shuguang Program, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DinoprostoneOvarian NeoplasmsHumansFemalePhosphofructokinasesPhosphofructokinase-1LiverGlucoseCell ProliferationCell Line, TumorNeoplasm Invasiveness

Stichwörter der Autor:innen

CP: CancerCP: MetabolismCRISPR-Cas9 screeningEMTPFKLPGE2PTGES3TET2fumarateinvasionmetastasisovarian cancer

Substanzen

DinoprostonePhosphofructokinasesPhosphofructokinase-1Glucose

Autor:innen und Institutionen

  • School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • iHuman Institute, ShanghaiTech University, Shanghai, China.
  • Interdisciplinary Research Center on Biology and Chemistry and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
  • Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University, and Key Laboratory of Metabolism and Molecular Medicine (Ministry of Education), and Shanghai Key Laboratory of Medical Epigene…
  • Interdisciplinary Research Center on Biology and Chemistry and Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. Electronic address: jiangzhu@sioc.ac.cn.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai, China; iHuman Institute, ShanghaiTech University, Shanghai, China. Electronic address: zhaosw@shanghaitech.edu.cn.

Förderung

  • Shanghai Shuguang Program
  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • ShanghaiTech University

Zitieren

APA

Chen, S., Wu, Y., Gao, Y., Wu, C., Wang, Y., Hou, C., Ren, M., Zhang, S., Zhu, Q., Zhang, J., Yao, Y., Huang, M., Qi, Y. B., Liu, X. S., Horng, T., Wang, H., Ye, D., Zhu, Z., Zhao, S., & Fan, G. (2023). Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113246

Vancouver

Chen S, Wu Y, Gao Y, Wu C, Wang Y, Hou C, et al. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113246

BibTeX
@article{Chen2023,
  author = {Chen, Shengmiao and Wu, Yiran and Gao, Yang and Wu, Chenxu and Wang, Yuetong and Hou, Chun and Ren, Miao and Zhang, Shuyuan and Zhu, Qi and Zhang, Jiali and Yao, Yufeng and Huang, Mei and Qi, Yingchuan B and Liu, Xue-Song and Horng, Tiffany and Wang, Haopeng and Ye, Dan and Zhu, Zhengjiang and Zhao, Suwen and Fan, Gaofeng},
  title = {Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113246}
}
Kostenlos starten →